Idiopathic pulmonary fibrosis (IPF) is the most common idiopathic interstitial pulmonary
disease with a median survival of 2–4 years after diagnosis. A significant number of IPF …

Skin is the largest organ of the human body. Being the interface between the body and the
outer environment, makes it susceptible to physical injury. To maintain life, nature has …

Idiopathic pulmonary fibrosis (IPF), a chronic and progressive fibrosing interstitial
pneumonia, is a fatal lung disease with a median survival time of 3–5 years. Problems in …

Introduction Idiopathic pulmonary fibrosis (IPF), a fatal lung disease of unknown origin, is
characterized by chronic and progressive fibrosing interstitial pneumonia which …

Purpose The RGD-integrin, αvβ6, plays a role in the pathogenesis of pulmonary fibrosis
through activation of transforming growth factor beta (TGFβ). This study sought to quantify …

Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease characterized by a
progressive-fibrosing phenotype. IPF has been associated with aberrant HDAC activities …

Fibrosis is the excessive deposition of extracellular matrix proteins into tissues leading to
scar formation, disruption of normal tissue architecture and organ failure. Despite the large …

Background Idiopathic pulmonary fibrosis (IPF) can severely damage lung function, which
may result in death. Emodin is a major ingredient of rhubarb and has been proven to protect …

Tissue injury can occur for a variety of reasons, including physical damage, infection, and
ischemia. The ability of tissues to effectively recover from injury is a cornerstone of human …

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease, and its molecular
pathogenesis remains poorly understood. Recently, emerging evidence demonstrates that …